Katarzyna M. Luda

Katarzyna M. Luda

Auto-generated profile, based on publicly available information

Katarzyna M. Luda

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, 2200 Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
IKIrem Kaymak
Irem Kaymak
MWMcLane J. Watson
McLane J. Watson
BOBrandon M. Oswald
Brandon M. Oswald
SMShixin Ma
Shixin Ma
BJBenjamin K. Johnson
Benjamin K. Johnson
RJRussell G. Jones
Russell G. Jones
Coordination of cellular metabolism is essential for optimal T cell responses. Here, we identify cytosolic acetyl-CoA production as an essential metabolic node for CD8 T cell function in vivo. We show that CD8 T cell responses to infection depend on acetyl-CoA derived from citrate via the enzyme ATP citrate lyase (ACLY). However, ablation of ACLY triggers an alternative, acetate-dependent pathway for acetyl-CoA production mediated by acyl-CoA synthetase short-chain family member 2 (ACSS2). Mechanistically, acetate fuels both the TCA cycle and cytosolic acetyl-CoA production, impacting T cell effector responses, acetate-dependent histone acetylation, and chromatin accessibility at effector gene loci. When ACLY is functional, ACSS2 is not required, suggesting acetate is not an obligate metabolic substrate for CD8 T cell function. However, loss of ACLY renders CD8 T cells dependent on acetate (via ACSS2) to maintain acetyl-CoA production and effector function. Together, ACLY and ACSS2 coordinate cytosolic acetyl-CoA production in CD8 T cells to maintain chromatin accessibility and T cell effector function.

23 February 2026 in Autophagy
Verified
Journal Article
Open access
FNFlorentina Negoita
Florentina Negoita
CBConchita Fraguas Bringas
Conchita Fraguas Bringas
KHKristina Hellberg
Kristina Hellberg
KLKatarzyna M. Luda
Katarzyna M. Luda
HLHongling Liu
Hongling Liu
KSKei Sakamoto
Kei Sakamoto
TFEB (transcription factor EB) and related TFE3 (transcription factor binding to IGHM enhancer 3) are members of the basic helix-loop-helix leucine zipper family of transcription factors [1]. TFEB ...

26 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KLKatarzyna M. Luda
Katarzyna M. Luda
SKSusan M. Kitchen-Goosen
Susan M. Kitchen-Goosen
EMEric H. Ma
Eric H. Ma
MWMcLane J. Watson
McLane J. Watson
LDLauren R. Duimstra
Lauren R. Duimstra
RJRussell G. Jones
Russell G. Jones
Environmental nutrient availability influences T cell metabolism, impacting T cell function and shaping immune outcomes. However, the metabolic pathways critical for optimal T cell responses remain poorly understood. Here, we identify ketone bodies (KBs) – including β-hydroxybutyrate (βOHB) and acetoacetate (AcAc) – as essential fuels supporting CD8 + T cell metabolism and effector function. Ketolysis is an intrinsic feature of highly functional CD8 + T effector (Teff) cells and βOHB directly increases CD8 + Teff cell IFN-γ production and cytolytic activity. Using metabolic tracers, we establish that CD8 + Teff cells preferentially use KBs over glucose to fuel the tricarboxylic acid (TCA) cycle in vitro and in vivo . KBs directly boost the respiratory capacity of CD8 + T cells and TCA cycle-dependent metabolic pathways that fuel T cell growth. Mechanistically, we find that βOHB is a major substrate for acetyl-CoA production in CD8 + T cells and regulates effector responses through effects on histone acetylation. Together, our results identify cell-intrinsic ketolysis as a metabolic and epigenetic driver of optimal CD8 + T cell effector responses. One Sentence summary: Ketone bodies promote CD8 + T cell metabolism and effector function through regulation of epigenetic programming

9 June 2026 in Molecular Metabolism
Verified
Journal Article
Open access
KLKatarzyna M. Luda
Katarzyna M. Luda
MAMarianne Agerholm
Marianne Agerholm
SSSi Brask Sonne
Si Brask Sonne
DBDipsikha Biswas
Dipsikha Biswas
LDLisa DeCamp
Lisa DeCamp
KSKei Sakamoto
Kei Sakamoto
White adipose tissue (WAT) plays a central role in maintaining systemic metabolic homeostasis by buffering lipid flux throughout the body. Impairment of this lipid-buffering capacity is a hallmark of obesity and has also been observed during chronic viral infection. Such dysfunction is closely associated with ectopic fat accumulation, particularly in the liver. We hypothesized that the coexistence of obesity and chronic viral infection exacerbates WAT dysfunction, thereby promoting liver pathology. However, the specific response of obese WAT to chronic viral infection - and its downstream impact on liver health - remains to be explored. To investigate this interaction, we employed a model of chronic viral infection in mice using lymphocytic choriomeningitis virus (LCMV) clone 13. In obese hosts, chronic infection caused sustained WAT depletion and progressive weight loss, accompanied by a reduction of Tim-4+ eWAT-resident macrophages and features reminiscent of lipodystrophy and aggravated metabolic dysfunction-associated steatotic liver disease (MASLD). Depletion of CD8+ T cells, the key mediators of LCMV-driven weight loss in lean mice, only modestly attenuated weight loss and did not ameliorate liver pathology in obese mice. Likewise, therapeutic interventions including TNF-α blockade and glycemic control with metformin did not reverse infection-induced weight loss; moreover, TNF-α blockade failed to improve liver pathology. Collectively, these findings reveal a previously unrecognized crosstalk between WAT and the liver in infection-driven MASLD, highlight distinct responses in WAT of obese mice compared to their lean counterpart, and underscore the increased susceptibility to virus-induced metabolic complications in obesity.